RPTECH (RPTECH): Acquisition / M&A
Rashi Peripherals (RPTECH) informed the NSE on 23 June that its board has approved an acquisition, according to the exchange filing. The company, which trades at a market capitalisation of ₹4,847 crore, disclosed the outcome after market hours without naming the target or deal value.
Strota's base rate for acquisition announcements — drawn from 141 comparable events — shows a 48.9% win rate with a net edge of 0.213 percentage points. This means events like this have historically produced slightly positive outcomes about half the time, with marginal average returns; the verdict is neutral-to-slightly-positive.
The stock currently trades at 17.85 times earnings and 2.39 times book value, with a return on equity of 14.9% and earnings per share of ₹41.2. Institutional flow data shows active two-way activity: on 17–18 June, proprietary trading firms including NK Securities Research, QE Securities, Microcurves Trading and Junomoneta Finsol executed paired buy-sell transactions worth ₹35–55 crore each, suggesting position adjustments rather than directional accumulation. The dividend yield stands at 0.27%.
The filing confirms a board-approved acquisition but does not establish the target, consideration, funding method, or accretion impact. The base rate offers historical context for this event type, not a forecast for RPTECH specifically.
The catalyst
Rashi Peripherals Limited has informed the Exchange about Acquisition (filing · NSE)
What the data shows after this event
Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.
RPTECH right now
P/E 17.85. Full RPTECH analysis →
Sources
- Rashi Peripherals Limited has informed the Exchange about Acquisition — NSE
- We Ran A Stock Scan For Earnings Growth And Rashi Peripherals (NSE:RPTECH) Passed With Ease — simplywall.st
- Rashi Peripherals Ltd (NSE:RPTECH) Q4 2026 Earnings Call Highlights: Record Revenue Growth and ... — GuruFocus.com
- Stocks to buy: Apollo Hospitals, Senores Pharma among analyst's top picks — Business Standard
- Rashi Peripherals Limited's (NSE:RPTECH) Price Is Right But Growth Is Lacking — simplywall.st
Keep digging
- RPTECH — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.